HPV Positive Bronchopulmonary Carcinomas in Women with Previous High-grade Cervical Intraepithelial Neoplasia (CIN III)

REFERENCES

• IARC (WHO). Patterns of cancer in five continents. 1990; 102 (Lyon).
   Google Scholar
• APMIS. Prediction of cancer mortality in the Nordic coun-tries up to the years 2000 and 2010. 1995; 103 (Suppl 49).
   Google Scholar
• Selikoff IJ, Hammond EC, Chyrg J. Asbestosis exposure, smoking and neoplasia. JAMA 1968; 204: 106–12.
   Google Scholar
• Loeb LA, Ernster VL, Warner KE, Abbots J, Laszio J. Smoking and lung cancer: an overview. Cancer Res 1984; 44: 5940–58.
   Google Scholar
• Newcomb PA, Carbone PP. The health consequences of smoking. Cancer Med Clin North Am 1992; 76: 305–31.
   PubMed Web of Science ®Google Scholar
• Thyssen J, Althoff J, Kimmerle G, Mohr V. Inhalation studies with benzo(a)pyrene in Syrian golden hamsters. J Natl Cancer Inst 1981; 66: 575–7.
   PubMed Web of Science ®Google Scholar
• Sellakumar A, Shubik P. Carcinogenity of different polycyclic hydrocarbons in the respiratory tract of hamsters. J Natl Cancer Inst 1974; 53: 1713–6.
   PubMedGoogle Scholar
• Hecht SS, Carmella SG, Murphy SE, Foiler PG, Chung FL. Carcinogen biomarkers related to smoking and upper aerodi-gestive tract cancer. J Cell Biochem 1993; (Suppl. 17F): 27–35.
   Google Scholar
• Watts SL, Brewer EE, Fry TL. Human papillomavirus DNA types in squamous cell carcinomas of the head and neck. Oral Surg Oral Med Oral Pathol 1991; 71: 701–7.
   PubMedGoogle Scholar
• Kasperbauer JL, O'Halloran GL, Espy MJ, Smith TF, Lewis JE. Polymerase chain reaction (PCR) identification of human papillomavirus (HPV) DNA in verrucous carcinoma of the larynx. Laryngoscope 1993; 103: 416–20.
   PubMed Web of Science ®Google Scholar
• Yousem SA, Ohori VP, Sonmez-Alpan E. Occurrence of human papillomavirus DNA in primary lung neoplasms. Can-cer 1992; 69: 693–7.
   Google Scholar
• Ogura H, Watanabe S, Fukushima K, Masuda Y, Fujiwara T, Yabe Y. Human papillomavirus DNA in squamous cell carcinomas of the respiratory and upper digestive tracts. Jpn J Clin Oncol 1993; 23: 221–5.
   PubMed Web of Science ®Google Scholar
• Li Q, Hu K, Pan X, Cao Z, Yang J, Hu S. Detection of human papilloma virus types 16, 18 DNA related sequences in bronchogenic carcinoma by polymerase chain reaction. Chin Med J Engl 1995; 108: 610–4.
   PubMed Web of Science ®Google Scholar
• Kinoshita I, Dosaka-Akita H, Shindoh M, et al., Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer 1995; 71: 344–9.
   PubMed Web of Science ®Google Scholar
• Noutsou A, Koffa M, Ergazaki M, Siafakas NM, Spandidos DA. Detection of human papillomavirus (HPV) and K-ras mutations in human lung carcinomas. Int .1- Oncol 1996; 8: 1089–93.
   Google Scholar
• Bejui-Thivolet F, Chardonnet Y, Patricot L. Human papillo-mavirus type 11 DNA in papillary squamous cell lung car-cinoma. Virchows Arch (A) 1990; 417: 457–61.
   Google Scholar
• Kashima HK, Kessis T, Mounts P, Shah K. Polymerase chain reaction identification of human papillomavirus DNA in CO, laser plume from recurrent respiratory papillomatosis. Otolar-yngol Head Neck Surg 1991; 104: 191–5.
   PubMed Web of Science ®Google Scholar
• Byrne JC, Tsao MS, Fraser RS, Howley PM. Human papillo-mavirus type 11 DNA in a patient with chronic laryngotra-cheobronchial papillomatosis and metastatic squamous cell carcinoma of the lung. N Engl J Med 1987; 317: 873–8.
   PubMed Web of Science ®Google Scholar
• Guillou L, Sahli R, Chaubert P, Monnier P, Cuttat J-F, Costa J. Squamous cell carcinoma of the lung in a nonsmok-ing, nonirradiated patient with juvenile larynotracheal papil-lomatosis. Evidence of human papillomavirus 11 DNA in both carcinoma and papillomatosis. Am J Surg Pathol 1991; 15: 891–8.
   Google Scholar
• Popper H, el Shabraw Y, Wockel W, et al. Prognostic impor-tance of human papillomavirus typing in squamous cell papil-loma of the bronchus: comparison of in situ hybridization and the polymerase chain reaction. Hum Pathol 1994; 25: 1191–7.
   PubMed Web of Science ®Google Scholar
• Gissmann L, Wolnik L, Ikenberg H, Koldovski U, Schnurch H C, zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Science USA 1983; 80: 560–3.
   Google Scholar
• Boshart M, zur Hausen H. Human papillomavirus in Buschke-Lovenstein tumors; physical state of the DNA and identification of a tandem duplication in the non-coding region of a human papillomavirus 6 subtype. J Virology 1986; 58: 963–6.
   PubMed Web of Science ®Google Scholar
• Turazza E, Lapena A, Sprovierei O, et al. Low-risk human papillomavirus types 6 and 11 associated with carcinomas of the genital and upper aero-digestive tract. Acta Obstet Gy-necol Scand 1997; 76: 271–6.
   PubMed Web of Science ®Google Scholar
• Grassmann K, Wilczynski SP, Cook N, Rapp B, Iftner T. HPV 6 variants from malignant tumors with sequence alter-ations in the regulatory region do not reveal differences in the activities of the oncogene promoters but do contain amino acid exchanges in the E6 and E7 proteins. Virology 1996; 223: 185–97.
   Google Scholar
• Band V, Dalal S, Delmolino L, Androphy EJ. Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immor-talized human mammary epithelial cells. EMBO 1993; 5: 1847–52.
   Google Scholar
• Thomas M, Massimi P, Jenkins J, Banks L. HPV-18 E6 mediated inhibition of p53 DNA binding activity is indepen-dent of E6 induced degradation. Oncogene 1995; 10: 261–8.
   PubMed Web of Science ®Google Scholar
• Boyer SN, Wazer DE, Band V. E7 protein of human papillo-mavirus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 1996; 56: 4620–4.
   Google Scholar
• Dyson N, Howley PM, Miinger K, Harlow E. The physical state of human papillomavirus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934–7.
   PubMed Web of Science ®Google Scholar
• Miinger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO 1989; 8: 4099–105.
   PubMed Web of Science ®Google Scholar
• Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo(a)pyrene adducts at lung cancer muta-tional hot spots in p53. Science 1996; 274: 430–2.
   PubMed Web of Science ®Google Scholar
• Bjorge T, Hennig EM, Skare GB, Soreide O, Thoresen S. Second primary cancers in patients with carcinoma in situ of the uterine cervix. The Norwegian experience 1970-1992. Int J Cancer 1995; 62: 29–33.
   Google Scholar
• Levi F, Randimbison L, La Vecchia C, Franceschi S. Inci-dence of invasive cancers following carcinoma in situ of the cervix. Br J Cancer 1996; 74: 1321–3.
   PubMed Web of Science ®Google Scholar
• Sturgeon SR, Curtis RE, Johnson K, Ries L, Brinton LA. Second primary cancers after vulvar and vaginal cancers. Am J Obstet Gyn 1996; 174: 929–33.
   Google Scholar
• Rabkin CS, Biggar RJ, Melbye M, Curtis RE. Second pri-mary cancers following anal and cervical carcinoma: evidence of shared etiological factors. Am J Epidem 1992; 136: 54–8.
   PubMed Web of Science ®Google Scholar
• Karlsen F, Kristensen G, Holm R, Chitmerere M, Berner A, Haar BM. High incidence of human papillomavirus in 146 cervical carcinomas. A study using three different pairs of consensus primers, and detecting viral genomes with putative deletions. Eur J Cancer 1995; 9: 1511–6.
   Google Scholar
• Buscema J, Naghashfar Z, Sawada E, Daniel R, Woodruff JD, Shah KV. The predominance of human papillomavirus type 16 in vulvar neoplasia. Obstet Gynecol 1988; 71: 601–6.
   PubMed Web of Science ®Google Scholar
• Scholefield JH, Palmer JG, Shepherd NA, Love S, Miller KJ, Northover JM. Clinical and pathological correlates of HPV type 16 DNA in anal cancer. Int J Colorect Dis 1990; 5: 219–22.
   PubMed Web of Science ®Google Scholar
• Scholefield JH, Kerr IB, Sheperd NA, Miller KJ, Bloomfield R, Northover JM. Human papillomavirus type 16 DNA in anal cancers from six different countries. Gut 1991; 32: 674–6.
   PubMed Web of Science ®Google Scholar
• Palefsky JM, Holly EA, Gonzales J, Berline J, Ahn DK, Greenspan JS. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res 1991; 51: 1014–9.
   PubMed Web of Science ®Google Scholar
• Pao CC, Lin S-S, Lin C-Y, Maa J-S, Lai C-H, Hsieh T-T. Identification of human papillomavirus DNA sequences in peripheral blood mononuclear cells. Am J Clin Pathol 1990; 95: 540–6.
   Google Scholar
• Mies C, Houldsworth J, Changanti RSK. Extraction of DNA from paraffin blocks for Southern-blot analysis. Am J Surg Pathol 1991; 15: 169–74.
   Google Scholar
• Human papillomavirus. Theoretical biology and biophysics. New Mexico, USA: Los Alamos National Laboratory, 1994.
   Google Scholar
• de Roda Husman A-M, Waalboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detec-tion by PCR. J Gen Virol 1995; 76:1057–62.
   PubMed Web of Science ®Google Scholar
• Arends MJ, Donaldson YK, Duvall E, Wyllie AH, Bird CC. HPV in full thickness cervical biopsies: high prevalence in CIN II and CIN III detected by a sensitive PCR method. J Pathol 1991; 165: 301–9.
   Google Scholar
• Karlsen F, Kalantari M, Jenkins A, et al. Use of multiple PCR sets for optimal detection of human papillomavirus. J Clin Microbiol 1996; 43: 2095–100.
   Google Scholar
• Gissmann L, Diehl V, Schultz-Coulon H-J, zur Hausen H. Molecular cloning and characterization of human papilloma virus DNA derived from laryngeal papilloma. J Virol 1982; 44: 393–400.
   Google Scholar
• Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of X-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350–4.
   PubMed Web of Science ®Google Scholar
• De Villiers EM, Gissmann L, zur Hausen H. Molecular cloning of viral DNA from genital warts. J Virol 1981; 40: 932–5.
   Google Scholar
• Diirst M, Gissman L, Ikenberg H, zur Hausen H. A papillo-mavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Sci USA 1983; 80: 3812–5.
   Google Scholar
• Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and cell lines derived from cervical cancer. EMBO 1984; 3: 1151–7.
   Google Scholar
• Holm R, Karlsen K, Nesland JM. In situ hybridization with non- isotopic probes using different detection systems. Mod Path 1992; 5: 315–20.
   Google Scholar
• Rapp B, Pawellek A, Kraetzer F, et al. Cell-type specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2. J Virol 1997; 71: 6956–66.
   PubMed Web of Science ®Google Scholar
• Park TW, Fujiwara H, Wright TC. Molecular biology of cervical cancer and its precursors. Cancer 1995; 76: 1902–13.
   Google Scholar
• Valle GF, Banks L. The human papillomavirus (HPV)-6 and HPV-I6 E5 proteins co-operate with HPV-I6 E7 in the trans-formation of primary rodent cells. J Gen Virol 1995; 76: 1239–45.
   PubMed Web of Science ®Google Scholar
• Conrad M, Goldstein D, Andresson T, Schlegel R. The E5 protein of HPV-6, but not HPV-I6, associates efficiently with cellular growth factor receptors. Virology 1994; 200: 796–800.
   PubMed Web of Science ®Google Scholar
• Halbert CL, Demers GW, Galloway DA. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol 1992; 66: 2125–34.
   Google Scholar
• Sang BC, Barbosa MS. Single amino acid substitutions in 'low-risk' human papillomavirus (HPV) type E7 protein en-hance features characteristic of the 'high-risk' HPV E7 onco-proteins. Proc Natl Acad Sci USA 1992; 89: 8063–7.
   PubMed Web of Science ®Google Scholar
• Fan A, Wang H, Kasher MS, Roman A. Relative enhancer activity and transforming potential of authentic human papil-lomavirus type 6 genomes from benign and malignant lesions. J Gen Virol 1991; 72: 519–26.
   PubMed Web of Science ®Google Scholar
• Icenogle JP, Sathya P, Miller DL, Tucker RA, Rawls WE. Nucleotide and amino acid sequence variation in the Li and E7 open reading frames of human papillomavirus type 6 and type 16. Virology 1991; 184: 101–7.
   Google Scholar
• Suzuki T, Tomita Y, Nagata H, Kono A, Simizu B. Nucleotide and amino acid sequence variations in the Li open reading frame of human papillomavirus type 6. J Med Virol 1997; 53: 19–24.
   Google Scholar
• Strang G, Hickling JK, McIndoe GAV, et al. Human T cell responses to human papillomavirus type 16 Li and E6 syn-thetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. J Gen Virol 1990; 71: 423–31.
   PubMed Web of Science ®Google Scholar
• Steele JC, Gallimore PH. Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 16 E7 gene that affect transformation, transactivation and phosphorylation by the E7 protein. J Gen Virol 1990; 71: 965–70.
   PubMed Web of Science ®Google Scholar
• Dillner J, Dillner L, Utter G, et al. Mapping of linear epitopes of human papillomavirus type 16: the Li and L2 open reading frames. Int .1- Cancer 1990; 45: 529–35.
   PubMed Web of Science ®Google Scholar
• Di Lonardo A, Venuti A, Marcante ML. Human papillo-mavirus in breast cancer. Breast Cancer Res Treat 1992; 21: 95–100.
   PubMed Web of Science ®Google Scholar
• Holm R, Tanum G, Karlsen F, Nesland JM. Prevalence and physical state of human papillomavirus DNA in anal car-cinomas. Mod Pathol 1994; 7: 449–53.
   PubMed Web of Science ®Google Scholar
• Stremlau A, Gissmann L, Ikenberg H, Stark M, Bannasch P. Human papillomavirus 16 related DNA in an anaplastic carcinoma of the lung. Cancer 1985; 55: 1737–40.
   Google Scholar
• Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM. Presence and expression of human papillomavirus se-quences in human cervical carcinoma cell lines. Am J Pathol 1985; 119: 361–6.
   PubMed Web of Science ®Google Scholar
• Masih AS, Stoler MH, Farrow GM, Johansson SL. Human papillomavirus in penile squamous cell lesions. A comparison of an isotopic RNA and two commercial nonisotopic DNA in situ hybridization methods. Arch Pathol Lab Med 1993; 117: 302–7.
   Google Scholar
• Saiki RK, Gelfand DH, Stiffel S, et al. Primer-directed enzy-matic amplification of DNA with a thermostable DNA poly-merase. Science 1988; 239: 487–91.
   PubMed Web of Science ®Google Scholar
• Yanuck MD, Kaufman RH, Woods KV, Adler-Stortz K. Cervical carcinoma metastatic to the skull, heart and lungs: analysis for the human papillomavirus DNA. Gynecol Oncol 1991; 42: 94–7.
   Google Scholar
• Helland A, Borresen AL, Kaern J, Ronningen KS, Thorsby E. HLA antigens and cervical carcinoma. Nature 1992; 356: 23.
   Google Scholar
• Tay SK, Jenkins D, Maddox P, Campion M, Singer A. Subpopulation of Langerhans' cells in cervical neoplasia. Br J Obstet Gynaecol 1987; 94: 10–5.
   Web of Science ®Google Scholar
• Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical car-cinoma show papillomavirus-type specificity. Nat Genet 1994; 6: 157–62.
   PubMed Web of Science ®Google Scholar
• Tay SK, Jenkins D, Maddox P, Singer A. Lymphocyte pheno-types in cervical intraepithelial neoplasia and human papillo-mavirus infection. Br J Obstet Gynaecol 1987; 94: 16–21.
   PubMedGoogle Scholar
• Petry KU, Scheffel D, Bode U, et al. Cellular immunodefi-ciency enhances the progression of human papillomavirus associated cervical lesions. Int J Cancer 1994; 67: 836–40.
   Google Scholar
• zur Hausen H. Intracellular surveillance of persisting viral infections. Human genital cancer results from deficient cellular control of papillomavirus gene expression. Lancet 1986; 2: 489–91.
   Google Scholar
• Haugen A. Lung cancer. Tidsskr Nor Lwgefor 1998; 118: 2362–5.
   PubMedGoogle Scholar
• Diirst M, Croce CM, Gissmann L, Schwartz E, Huebner K. Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci 1987; 84: 1070–4.
   Google Scholar
• Cannizzarro LA, Diirst M, Mendez M, Hecht BK, Hecht F. Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genet Cytogenet 1988; 33: 93–8.
   Google Scholar
• Popescu NC, Zimonjic D, Di Paolo JA. Viral integration, fragile sites, and proto-oncogens in human neoplasia. Hum Genet 1990; 84: 383–6.
   Google Scholar
• Engeland A, Haldorsen T, Andersen A, Tretli S. The impact of smoking habits on lung cancer risk: 28 years' observation of 26000 Norwegian men and women. Cancer Causes Control 1996; 7: 366–76.
   PubMed Web of Science ®Google Scholar
• Langmark F, Hagen S. Kreft. Helseregion I. The Norwegian Cancer Registry 1990.
   Google Scholar
• Engeland A, Andersen A, Haldorsen T, Tretli S. Smoking habits and risk of cancers other than lung cancer: 28 years' follow-up of 26000 Norwegian men and women. Cancer Causes Control 1996; 7: 497–506.
   PubMed Web of Science ®Google Scholar